Fosun Pharma
600196.SS
#2220
Rank
NZ$15.36 B
Marketcap
NZ$5.75
Share price
-0.09%
Change (1 day)
-16.00%
Change (1 year)

Earnings for Fosun Pharma (600196.SS)

Earnings in 2026 (TTM): NZ$1.29 Billion

According to Fosun Pharma's latest financial reports the company's current earnings are NZ$5.92 Billion. In 2024 the company made an earning of NZ$0.97 Billion, an increase over its 2023 earnings that were of NZ$0.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fosun Pharma from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$1.29 B
2024 NZ$0.97 B25.44%
2023 NZ$0.78 B-31.53%
2022 NZ$1.14 B-28.08%
2021 NZ$1.58 B37.28%
2020 NZ$1.15 B4.48%
2019 NZ$1.10 B21.16%
2018 NZ$0.91 B-10.83%
2017 NZ$1.02 B12.72%
2016 NZ$0.90 B0.24%
2015 NZ$0.90 B22.63%
2014 NZ$0.73 B-8.16%
2013 NZ$0.80 B40.92%
2012 NZ$0.57 B25.97%
2011 NZ$0.45 B50.49%
2010 NZ$0.30 B-62.8%
2009 NZ$0.80 B294.46%
2008 NZ$0.20 B19.26%
2007 NZ$0.17 B136.37%
2006 NZ$72.79 M31.44%
2005 NZ$55.38 M-13.45%
2004 NZ$63.99 M-10.03%
2003 NZ$71.12 M98.84%
2002 NZ$35.77 M